← Back
Data updated: Mar 10, 2026
BIOCRYST
Ophthalmology
BIOCRYST is a pharmaceutical company focused on Ophthalmology. Key products include RAPIVAB.
2014
Since
2
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
Recent Activity
ORLADEYO 2025-12-23
Labeling
ORLADEYO 2025-12-11
Type 3 - New Dosage Form
ORLADEYO 2024-10-21
Labeling
RAPIVAB 2024-06-13
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Ophthalmology 100%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...